Based on the data from GEPIA and our HCC samples from clinical patients, the major components (YAP and TAZ) in HIPPO pathway were closely associated with the FGF21 and IL-17A expression levels in regard to the prognosis. This evidence concerns the gene IL17A and hepatocellular carcinoma.